Work

Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.

Year: 2011

Type: article

Study design: Case Report

Source: PubMed

Authors: David R Fogelman, Robert A Wolff, Scott Kopetz, Milind Javle, Charles Bradley, Isabel Mok, Fernando Cabanillas, James L Abbruzzese

Institutions: The University of Texas MD Anderson Cancer Center, Bipar, Auxilio Mutuo Hospital

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2114734643

FWCI: 6.227

Cites: 15

Cited by: 91

Related to: 10